Presentation is loading. Please wait.

Presentation is loading. Please wait.

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith.

Published byClemence Conley Modified over 6 years ago

Similar presentations

Presentation on theme: "National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith."— Presentation transcript:

1 National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith M. Kramer, MD, MS, Bradley Hammill, MA, Kevin J. Anstrom, PhD, Donald Fetterolf, MD, MBA, Richard Snyder, MD, John P. Charde, MD, Barbara S. Hoffman, PA-C, MBA, Nancy Allen LaPointe, PharmD, Eric Peterson, MD, MPH  American Heart Journal  Volume 152, Issue 3, Pages 454.e1-454.e8 (September 2006) DOI: /j.ahj Copyright © 2006 Mosby, Inc. Terms and Conditions

2 Figure 1 National adherence by cumulative time intervals.
American Heart Journal  , 454.e1-454.e8DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions

3 Figure 2 National adherence for cumulative time intervals by health plan product for patients aged 35 to 64 (A) and ≥65 years (B). American Heart Journal  , 454.e1-454.e8DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions

4 Figure 3 Adherence over 360 days by region and product. Kruskall-Wallis test: All patients: P < ; Medicare + Choice: P = 0.04. American Heart Journal  , 454.e1-454.e8DOI: ( /j.ahj ) Copyright © 2006 Mosby, Inc. Terms and Conditions

Download ppt "National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance  Judith."

Similar presentations

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.
Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.
Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm  Griselda Gutierrez, MD, FACOG, Joy.

Management of severe anemia secondary to menorrhagia in a Jehovah's Witness: a case report and treatment algorithm  Griselda Gutierrez, MD, FACOG, Joy.
Joann R. Petrini, PhD, MPH, Todd Dias, MS, Marie C

Joann R. Petrini, PhD, MPH, Todd Dias, MS, Marie C
Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.
Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,

Atrial fibrillation and quality of life after pacemaker implantation for sick sinus syndrome: Data from the Mode Selection Trial (MOST)  Kirsten E. Fleischmann,
Downstream coronary effects of drug-eluting stents

Downstream coronary effects of drug-eluting stents
Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results.

Exercise capacity and quality of life after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: Results.
Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E
Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD 
The Epidemic of the 20th Century: Coronary Heart Disease

The Epidemic of the 20th Century: Coronary Heart Disease
The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics  Cheryl Bushnell,

The Adherence eValuation After Ischemic Stroke Longitudinal (AVAIL) Registry: Design, rationale, and baseline patient characteristics  Cheryl Bushnell,
Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.

Evaluation of a novel anti-ischemic agent in acute coronary syndromes: Design and rationale for the Metabolic Efficiency with Ranolazine for Less Ischemia.
Increasing Exposure to Antibody-Stimulating Proteins and Polysaccharides in Vaccines Is Not Associated with Risk of Autism  Frank DeStefano, MD, MPH,

Increasing Exposure to Antibody-Stimulating Proteins and Polysaccharides in Vaccines Is Not Associated with Risk of Autism  Frank DeStefano, MD, MPH,
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population  Richard K. Cheng, MD, MS,

Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population  Richard K. Cheng, MD, MS,
Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: The.

Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: The.
Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Hany S. Abed, BPharm, MBBS, PhD,

Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation  Hany S. Abed, BPharm, MBBS, PhD,
Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.
Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.

Gender differences in adverse outcomes after contemporary percutaneous coronary intervention: An analysis from the Blue Cross Blue Shield of Michigan.
Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization:

Similar presentations

Ads by Google